Arca
Skip to content

KCNN4: Intermediate conductance calcium-activated potassium channel protein 4

A drug works by acting on something in the body, usually a protein made by one gene. This is a page for each of those targets: the drugs that hit it and the diseases it is tied to.

Intermediate conductance calcium-activated potassium channel that mediates the voltage-independent transmembrane transfer of potassium across the cell membrane through a constitutive interaction with calmodulin which binds the intracellular calcium allowing its opening.

  • Drugs that act on it: 2
  • With a US drug page: 1
  • Type: Protein

Drugs That Act on It

Approved and clinical-stage drugs ChEMBL records for this target; those with a US approval link to their page
ChlorzoxazoneApprovedIntermediate conductance calcium-activated potassium channel protein 4 openerOpener—
Senicapoc—Intermediate conductance calcium-activated potassium channel protein 4 blockerBlocker—

Diseases Most Associated With It

Open Targets association score, 0 to 1; all associations
Dehydrated hereditary stomatocytosis
0.72
Breast carcinoma
0.42
Hereditary disease
0.41
Dehydrated hereditary stomatocytosis with or without pseudohyperkalemia and/or perinatal edema
0.35
Luminal A breast carcinoma
0.30
Alzheimer disease
0.13
Kartagener Syndrome
0.12
Neoplasm
0.12

Drugs and mechanisms are from ChEMBL CHEMBL4305 (CC BY-SA 3.0). Gene name, function (UniProt O15554, CC BY 4.0) and disease associations are from Open Targets (CC0). ChEMBL and Open Targets

Logos are each company's own site icon, matched by name through Wikidata.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.